International audienceBackground - Changes in relapse activity during secondary progressive multiple sclerosis (SPMS) need to be accurately characterized in order to identify patients who might benefit from continuing disease-modifying therapies.Objective - To describe relapse occurrence in patients with SPMS during long-term follow-up and assess its impact on disability worsening. Methods - This retrospective cohort study included 506 patients. We assessed the influence of relapses on time from SPMS onset to an Expanded Disability Status Scale score of 6 (EDSS 6), and on irreversible worsening of EDSS scores across different periods.Results - The annualized relapse rate (ARR) decreased with patient's age (mean reduction of 43% per decade)...
OBJECTIVES: To assess factors affecting the rate of conversion to secondary progressive (SP) multipl...
International audienceBACKGROUND: Long-term effectiveness of treatment remains a key question in mul...
International audienceBACKGROUND: Long-term effectiveness of treatment remains a key question in mul...
International audienceBackground - Changes in relapse activity during secondary progressive multiple...
Importance: It is unclear whether relapses and disease-modifying therapies are associated with the r...
Importance: It is unclear whether relapses and disease-modifying therapies are associated with the r...
Importance: It is unclear whether relapses and disease-modifying therapies are associated with the r...
It is unclear whether relapses and disease-modifying therapies are associated with the rate of disab...
It is unclear whether relapses and disease-modifying therapies are associated with the rate of disab...
Background: Whether progression independent of relapse activity (PIRA) heralds earlier onset of seco...
Objective Rates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be s...
OBJECTIVES: To investigate the relationship among attacks in the first 2 years (early relapses), sec...
The impact of relapses on long-term disability in multiple sclerosis remains unclear; however some e...
ObjectiveRates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be su...
ObjectiveRates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be su...
OBJECTIVES: To assess factors affecting the rate of conversion to secondary progressive (SP) multipl...
International audienceBACKGROUND: Long-term effectiveness of treatment remains a key question in mul...
International audienceBACKGROUND: Long-term effectiveness of treatment remains a key question in mul...
International audienceBackground - Changes in relapse activity during secondary progressive multiple...
Importance: It is unclear whether relapses and disease-modifying therapies are associated with the r...
Importance: It is unclear whether relapses and disease-modifying therapies are associated with the r...
Importance: It is unclear whether relapses and disease-modifying therapies are associated with the r...
It is unclear whether relapses and disease-modifying therapies are associated with the rate of disab...
It is unclear whether relapses and disease-modifying therapies are associated with the rate of disab...
Background: Whether progression independent of relapse activity (PIRA) heralds earlier onset of seco...
Objective Rates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be s...
OBJECTIVES: To investigate the relationship among attacks in the first 2 years (early relapses), sec...
The impact of relapses on long-term disability in multiple sclerosis remains unclear; however some e...
ObjectiveRates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be su...
ObjectiveRates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be su...
OBJECTIVES: To assess factors affecting the rate of conversion to secondary progressive (SP) multipl...
International audienceBACKGROUND: Long-term effectiveness of treatment remains a key question in mul...
International audienceBACKGROUND: Long-term effectiveness of treatment remains a key question in mul...